Article info
PDFCerebrovascular disease
Review
Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?
- Correspondence to Dr Konstantinos Stavropoulos, Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration Hospital, St. Konstantinoupoleos 49, Thessaloniki 54642, Greece; konvstavropoulos{at}hotmail.com
Citation
Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?
Publication history
- Received August 18, 2016
- Accepted November 9, 2016
- First published November 28, 2016.
Online issue publication
February 17, 2017
Article Versions
- Previous version (17 February 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/